Alliancebernstein L.P. Trans Medics Group, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 40,072 shares of TMDX stock, worth $2.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,072

Previous 38,630 3.73%

Holding current value

$2.57 Million

Previous $5.82 Million 8.13%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$135.68 - $176.11 $195,650 - $253,950	1,442 Added 3.73%	40,072 $6.29 Million
Q2 2024 Aug 14, 2024	BUY	$72.62 - $150.62 $506,161 - $1.05 Million	6,970 Added 22.02%	38,630 $5.82 Million
Q1 2024 May 14, 2024	SELL	$70.86 - $89.93 $413,822 - $525,191	-5,840 Reduced 15.57%	31,660 $2.34 Million
Q2 2023 Aug 15, 2023	BUY	$66.23 - $88.73 $384,134 - $514,634	5,800 Added 18.3%	37,500 $3.15 Million
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $418,156 - $687,903	10,700 Added 50.95%	31,700 $1.96 Million
Q4 2021 Feb 14, 2022	SELL	$19.16 - $32.68 $40,236 - $68,628	-2,100 Reduced 9.09%	21,000 $402,000
Q1 2021 May 06, 2021	SELL	$17.75 - $47.82 $26,625 - $71,730	-1,500 Reduced 6.1%	23,100 $958,000
Q2 2020 Aug 13, 2020	BUY	$11.66 - $18.26 $67,628 - $105,908	5,800 Added 30.85%	24,600 $441,000
Q1 2020 May 14, 2020	BUY	$10.5 - $20.2 $72,450 - $139,380	6,900 Added 57.98%	18,800 $227,000
Q4 2019 Feb 18, 2020	BUY	$16.61 - $21.64 $11,627 - $15,148	700 Added 6.25%	11,900 $226,000
Q3 2019 Nov 14, 2019	BUY	$20.27 - $28.93 $227,024 - $324,016	11,200 New	11,200 $266,000

Others Institutions Holding TMDX

# of Institutions

398

Shares Held

31.9M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.04B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Trans Medics Group, Inc. Transaction History